Susquehanna International Group’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-673
Closed -$16K 14124
2025
Q4
$16K Buy
673
+3
+0.4% +$88 ﹤0.01% 12001
2025
Q3
$20.9K Buy
+670
New +$21.1K ﹤0.01% 12046
2024
Q4
Sell
-357
Closed -$11.8K 13242
2024
Q3
$11.8K Buy
+357
New +$24.1K ﹤0.01% 11704
2022
Q4
Sell
-93
Closed -$15K 13690
2022
Q3
$15K Buy
+93
New +$18K ﹤0.01% 12703
2022
Q1
Sell
-122
Closed -$26K 13981
2021
Q4
$26K Sell
122
-155
-56% -$44K ﹤0.01% 12775
2021
Q3
$90K Sell
277
-456
-62% -$160K ﹤0.01% 12120
2021
Q2
$323K Buy
733
+60
+9% +$29.9K ﹤0.01% 10611
2021
Q1
$379K Buy
673
+424
+170% +$306K ﹤0.01% 10104
2020
Q4
$142K Buy
249
+145
+139% +$72K ﹤0.01% 10282
2020
Q3
$31K Buy
104
+23
+28% +$7.99K ﹤0.01% 10321
2020
Q2
$26K Buy
+81
New +$18.5K ﹤0.01% 9889
2017
Q3
Sell
-113
Closed -$101K 9640
2017
Q2
$101K Sell
113
-4
-3% -$3.4K ﹤0.01% 8680
2017
Q1
$104K Buy
+117
New +$110K ﹤0.01% 8371
2016
Q1
Sell
-95
Closed -$168K 9680
2015
Q4
$168K Sell
95
-14
-13% -$24.8K ﹤0.01% 8559
2015
Q3
$186K Sell
109
-2
-2% -$4.83K ﹤0.01% 8764
2015
Q2
$300K Sell
111
-110
-50% -$286K ﹤0.01% 8533
2015
Q1
$637K Sell
221
-62
-22% -$172K ﹤0.01% 6654
2014
Q4
$742K Sell
283
-414
-59% -$1.07M ﹤0.01% 6450
2014
Q3
$1.91M Sell
697
-34
-5% -$110K ﹤0.01% 4698
2014
Q2
$2.52M Buy
731
+563
+335% +$2M ﹤0.01% 4207
2014
Q1
$611K Buy
168
+95
+130% +$374K ﹤0.01% 6395
2013
Q4
$277K Buy
+73
New +$263K ﹤0.01% 7712

Other funds holding TRIB

Susquehanna International Group's TRIB Position: Q1 2026 in Review

Susquehanna International Group sold out of Trinity Biotech (TRIB) in Q1 2026, closing a stake of 475 shares — an estimated $10.5K sold.

Susquehanna International Group first reported a position in TRIB in Q3 2013 and held it in 24 quarters. The position peaked at $1.02M in Q2 2014. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Susquehanna International Group reported no remaining Trinity Biotech position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 475 Trinity Biotech shares in Q1 2026, an estimated $10.5K.
  • Susquehanna International Group first reported a position in Trinity Biotech in Q3 2013 and held it in 24 quarters.
  • Susquehanna International Group's Trinity Biotech position peaked at $1.02M in Q2 2014.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.